0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
ARTICLE |

The Angiotensin Amide Skin Test:  A Nonspecific Reaction

Cooper G. Hazelrig, MD; Philip J. Osmundson, MD; Alexander Schirger, MD; Sheldon G. Sheps, MD; John F. Fairbairn II, MD
JAMA. 1963;186(5):507. doi:10.1001/jama.1963.63710050032013.
Text Size: A A A
Published online

AFTER THE CHARACTERIZATION and synthesis of angiotensin amide and the discovery of a depressor fraction in blood, Jablons1,2 suggested the possible use of intradermally injected angiotensin amide as a diagnostic tool in hypertension. He theorized that individuals might have varied responses to angiotensin amide depending on the relative balance of pressor material (angiotensin II) and depressor material (angiotensin inhibitor) present in the circulatory system. Jablons found that the characteristic circumscribed area of blanching and induration produced by the intradermal injection of 0.05 to 0.1μg of angiotensin amide in saline solution persisted longer in hypertensive patients than in normal persons. Preliminary studies had indicated that more than 90% of the normal persons tested had areas of induration and blanching that persisted for less than 30 min, whereas more than 90% of the hypertensive persons had induration and blanching that lasted for more than 30 min.

The present study was

Topics

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

First Page Preview

View Large
First page PDF preview

Figures

Tables

References

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs
brightcove.createExperiences();